Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merrimack Pharmaceuticals

15.13
0.0000
Volume:- -
Turnover:- -
Market Cap:223.75M
PE:1.08
High:15.13
Open:15.13
Low:15.13
Close:15.13
Loading ...
Mar 09, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2021

Major Issues Report

8-K - Current report
Jun 14, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 11, 2021

Major Issues Report

8-K - Current report
Mar 10, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 03, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 02, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 05, 2020

Major Issues Report

8-K - Current report
Nov 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2020

Major Issues Report

8-K - Current report
Aug 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]